CompuMed Financials

CMPD Stock  USD 4.26  0.13  2.96%   
Please use analysis of CompuMed fundamentals to determine if markets are correctly pricing the company. We were able to interpolate data for thirty-two available fundamental indicators for CompuMed, which can be compared to its peers. The stock experiences an unexpected downward movement. The market is reacting to new fundamentals. Check odds of CompuMed to be traded at $4.09 in 90 days.
  
Understanding current and past CompuMed Financials, including the trends in assets, liabilities, equity and income are directly related to making proper and timely investing decisions. All of CompuMed's financial statements are interrelated, with each one affecting the others. For example, an increase in CompuMed's assets may result in an increase in income on the income statement.
Please note, the presentation of CompuMed's financial position, as portrayed in its financial statements, is often influenced by management's estimates, judgments, and sometimes even manipulations. In the best case, CompuMed's management is honest, while the outside auditors are strict and uncompromising. Please utilize our Beneish M Score to check the likelihood of CompuMed's management manipulating its earnings.

CompuMed Stock Summary

CompuMed competes with Healthlynked Corp, Mosaic Immunoengineerin, and Vycor Medical. CompuMed, Inc., an enterprise telemedicine solutions company, provides clinical care services for patients and medical facilities. CompuMed, Inc. was founded in 1973 and is headquartered in Los Angeles, California. Compumed operates under Health Information Services classification in the United States and is traded on OTC Exchange. It employs 8 people.
InstrumentUSA Pink Sheet View All
ExchangePINK Exchange
ISINUS2049144023
Business Address5777 West Century
SectorHealth Care Technology
IndustryHealth Care
BenchmarkDow Jones Industrial
Websitewww.compumed.net
Phone310 258 5000
CurrencyUSD - US Dollar

CompuMed Key Financial Ratios

There are many critical financial ratios that CompuMed's investors are exposed to on a daily basis, but they are usually grouped into few meaningful categories from each financial statement that CompuMed reports annually and quarterly.

CompuMed Financial Ratios Relationships

Comparative valuation techniques use various fundamental indicators to help in determining CompuMed's current stock value. Our valuation model uses many indicators to compare CompuMed value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across CompuMed competition to find correlations between indicators driving CompuMed's intrinsic value. More Info.
CompuMed is rated second in return on equity category among its peers. It also is rated second in return on asset category among its peers . The reason why the comparable model can be used in almost all circumstances is due to the vast number of multiples that can be utilized, such as the price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S), price-to-cash flow (P/CF), and many others. The P/E ratio is the most commonly used of these ratios because it focuses on the CompuMed's earnings, one of the primary drivers of an investment's value.

CompuMed January 17, 2026 Opportunity Range

Along with financial statement analysis, the daily predictive indicators of CompuMed help investors to analyze its daily demand and supply, volume, patterns, and price swings to determine the real value of CompuMed. We use our internally-developed statistical techniques to arrive at the intrinsic value of CompuMed based on widely used predictive technical indicators. In general, we focus on analyzing CompuMed Pink Sheet price patterns and their correlations with different microeconomic environment and drivers. We also apply predictive analytics to build CompuMed's daily price indicators and compare them against related drivers.

Complementary Tools for CompuMed Pink Sheet analysis

When running CompuMed's price analysis, check to measure CompuMed's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy CompuMed is operating at the current time. Most of CompuMed's value examination focuses on studying past and present price action to predict the probability of CompuMed's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move CompuMed's price. Additionally, you may evaluate how the addition of CompuMed to your portfolios can decrease your overall portfolio volatility.
Commodity Channel
Use Commodity Channel Index to analyze current equity momentum
Theme Ratings
Determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance
Watchlist Optimization
Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm
Stocks Directory
Find actively traded stocks across global markets
Risk-Return Analysis
View associations between returns expected from investment and the risk you assume
Performance Analysis
Check effects of mean-variance optimization against your current asset allocation
Equity Forecasting
Use basic forecasting models to generate price predictions and determine price momentum